VREX · CIK 0001681622 · operating
Varex Imaging Corporation designs and manufactures X-ray imaging components for medical and industrial applications. The company produces X-ray tubes, digital detectors, high voltage connectors, ionization chambers, generators, and associated software and accessories. Its product portfolio also includes image-processing and 3D reconstruction software, computer-aided diagnostic tools, and thermal management equipment. The company distributes products through original equipment manufacturers, independent service companies, distributors, and direct sales to end-users.
The Medical segment represents the company's primary business, supplying components for computed tomography, mammography, cardiac imaging, oncology, surgical, dental, and diagnostic radiography systems. The Industrial segment manufactures X-ray linear accelerators and non-intrusive inspection systems used in airport baggage screening, cargo inspection at ports and borders, nondestructive testing, and industrial irradiation applications.
Varex operates a global footprint spanning North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia, with approximately 2,400 full-time employees. The company was incorporated in Delaware in 2016 and is headquartered in Salt Lake City, Utah. It trades on the Nasdaq under ticker VREX.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.70 | $-1.70 | -45.3% | |
| 2024 | $-1.17 | $-1.17 | -208.3% | |
| 2023 | $1.08 | $1.20 | +47.9% | |
| 2022 | $0.73 | $0.76 | +69.8% | |
| 2021 | $0.43 | $0.44 | +128.9% | |
| 2020 | $-1.49 | $-1.49 | -472.5% | |
| 2019 | $0.40 | $0.41 | -44.4% | |
| 2018 | $0.72 | $0.73 | -47.1% | |
| 2017 | $1.36 | $1.37 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-10-03 | 2025-11-18 | 0001681622-25-000108 | SEC ↗ |
| 2024-09-27 | 2024-11-19 | 0001681622-24-000089 | SEC ↗ |
| 2023-09-29 | 2023-11-16 | 0001681622-23-000074 | SEC ↗ |
| 2022-09-30 | 2022-11-18 | 0001681622-22-000091 | SEC ↗ |
| 2021-10-01 | 2021-11-19 | 0001681622-21-000103 | SEC ↗ |
| 2020-10-02 | 2020-11-30 | 0001681622-20-000116 | SEC ↗ |
| 2019-09-27 | 2019-12-20 | 0001681622-19-000083 | SEC ↗ |
| 2018-09-28 | 2018-11-27 | 0001681622-18-000045 | SEC ↗ |
| 2017-09-29 | 2017-12-13 | 0001681622-17-000023 | SEC ↗ |